SEC 13F Intelligence

Checkpoint Capital L.P. / KYMR

Checkpoint Capital L.P.’s Kymera Therapeutics Inc Position

Does Checkpoint Capital L.P. own Kymera Therapeutics Inc (KYMR)? Not currently — the last reported position was 61.8K shares worth $3M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q3 2025
Shares
61.8K
% of Portfolio
+1.17%
Quarters Held
5
position exited

Position History KYMR

Reported value by quarter
Q2 ’24: $2MQ2 ’24Q4 ’24: $3MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $5MQ2 ’25Q3 ’25: $3MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202561.8K$3M+1.17%
Q2 2025107.0K$5M+2.18%
Q1 2025136.6K$4M+2.05%
Q4 202477.5K$3M+1.59%
Q2 202482.0K$2M+1.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of KYMR.